Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors -- a smart fighter that destroys cancer cells for days without tiring. Biomedical engineers have made this ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Immunotherapy Research: Independently design, plan, and execute experiments involving CAR-T cell engineering, optimization, and evaluation using advanced cellular, molecular, and immunological ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

On the first day of his administration, President Donald Trump signed an executive order directing the federal government to ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team from the Technical University of Munich (TUM) and Helmholtz ...

The Postdoctoral Scholar will lead innovative research projects focused on the development and evaluation of immunotherapies for brain tumors, with an emphasis on CAR-T cell therapy. This position ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team has now uncovered this mechanism. The scientists showed ...

Tertiary lymphoid structures (TLS) are increasingly recognized to have roles in cancer. Within tumor microenvironments (TME), TLS can arise as ectopic lymphoid organs containing aggregates of ...